Skip to content
MedsAcross

Medicine

Fludeoxyglucose F18 300 mCi/mL injection

Fludeoxyglucose f-18 · Intravenous · Biomedical Research Foundation of Northwest Louisiana
Available on requestPrescription onlyUS FDA

Fludeoxyglucose F18 300 mCi/mL injection is a prescription medicine containing Fludeoxyglucose f-18 for intravenous use, marketed by Biomedical Research Foundation of Northwest Louisiana, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store the Fludeoxyglucose F18 Injection USP vial upright in a lead shielded…

Key facts

Active ingredient (INN)
Fludeoxyglucose f-18
Brand
Fludeoxyglucose F18
Strength
300 mCi/mL
Dosage form
Injection
Route
Intravenous
Packs
30 mL
Marketing authorisation holder
Biomedical Research Foundation of Northwest Louisiana
Manufacturer
Biomedical Research Foundation of Northwest Louisiana
Origin register
US FDA, United States
Storage
Store the Fludeoxyglucose F18 Injection USP vial upright in a lead shielded container at 25°C (77°F), excursions permitted to 15 to 30°C (59 to 85°F). Store and dispose of Fludeoxyglucose F 18 Injection USP in accordance with the regulations and a general license, or its equivalent, of an Agreement State or a Licensing State.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
V09IX04 Fludeoxyglucose f-18
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
14 May 2015
Identifiers
DailyMed set ID edb15e3c-848d-433d-9f1c-c73a3c72861bNDC 24562-003Application ANDA203837

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
30 mL in 1 vial, glass24562-003-30Biomedical Research Foundation of Northwest Louisiana14 May 2015

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 August 1994Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Fludeoxyglucose f-18 300 mCi/mL injection.

Compare 1

Other strengths and forms of Fludeoxyglucose f-18

Clinical summary

Fludeoxyglucose f-18 is a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging in settings, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Fludeoxyglucose f-18 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Fludeoxyglucose f-18

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Fludeoxyglucose F18 300 mCi/mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.